These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8075982)

  • 1. The crystal structure of pertussis toxin.
    Stein PE; Boodhoo A; Armstrong GD; Cockle SA; Klein MH; Read RJ
    Structure; 1994 Jan; 2(1):45-57. PubMed ID: 8075982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of a pertussis toxin-sugar complex as a model for receptor binding.
    Stein PE; Boodhoo A; Armstrong GD; Heerze LD; Cockle SA; Klein MH; Read RJ
    Nat Struct Biol; 1994 Sep; 1(9):591-6. PubMed ID: 7634099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the pertussis toxin-ATP complex: a molecular sensor.
    Hazes B; Boodhoo A; Cockle SA; Read RJ
    J Mol Biol; 1996 May; 258(4):661-71. PubMed ID: 8637000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The subunit S1 is important for pertussis toxin secretion.
    Pizza M; Bugnoli M; Manetti R; Covacci A; Rappuoli R
    J Biol Chem; 1990 Oct; 265(29):17759-63. PubMed ID: 2211659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.
    Lobet Y; Feron C; Dequesne G; Simoen E; Hauser P; Locht C
    J Exp Med; 1993 Jan; 177(1):79-87. PubMed ID: 8418210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit.
    Locht C; Antoine R
    Biochimie; 1995; 77(5):333-40. PubMed ID: 8527486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis toxin gene: nucleotide sequence and genetic organization.
    Locht C; Keith JM
    Science; 1986 Jun; 232(4755):1258-64. PubMed ID: 3704651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin.
    Antoine R; Locht C
    Infect Immun; 1990 Jun; 58(6):1518-26. PubMed ID: 2341166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
    Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
    Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the lectin-like binding domains in pertussis toxin using synthetic peptide sequences. Identification of a sialic acid binding site in the S2 subunit of the toxin.
    Heerze LD; Chong PC; Armstrong GD
    J Biol Chem; 1992 Dec; 267(36):25810-5. PubMed ID: 1281475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H; Sato Y
    FEMS Microbiol Lett; 1994 Jan; 115(1):63-9. PubMed ID: 7510256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication.
    Nicosia A; Perugini M; Franzini C; Casagli MC; Borri MG; Antoni G; Almoni M; Neri P; Ratti G; Rappuoli R
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4631-5. PubMed ID: 2873570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion.
    Farizo KM; Fiddner S; Cheung AM; Burns DL
    Infect Immun; 2002 Mar; 70(3):1193-201. PubMed ID: 11854200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit.
    Bartley TD; Whiteley DW; Mar VL; Burns DL; Burnette WN
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8353-7. PubMed ID: 2554311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of holotoxin assembly in Ptl-mediated secretion of pertussis toxin from Bordetella pertussis.
    Farizo KM; Huang T; Burns DL
    Infect Immun; 2000 Jul; 68(7):4049-54. PubMed ID: 10858221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of amino acid residues essential for the enzymatic activities of pertussis toxin.
    Locht C; Capiau C; Feron C
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3075-9. PubMed ID: 2470088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary X-ray crystallographic analysis of holotoxin from Bordetella pertussis.
    Raghavan M; Gotto JW; Scott JV; Schutt CE
    J Mol Biol; 1990 Jun; 213(3):411-4. PubMed ID: 2352276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.
    Domenighini M; Magagnoli C; Pizza M; Rappuoli R
    Mol Microbiol; 1994 Oct; 14(1):41-50. PubMed ID: 7830559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity.
    Pizza M; Bartoloni A; Prugnola A; Silvestri S; Rappuoli R
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7521-5. PubMed ID: 2902632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.